A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group

Meredith K. Chuk, Brigitte C. Widemann, Charles G. Minard, Xiaowei Liu, Ae Rang Kim, Melanie Brooke Bernhardt, Rachel A. Kudgus, Joel M Reid, Stephan D. Voss, Susan Blaney, Elizabeth Fox, Brenda J. Weigel

Research output: Contribution to journalArticle

5 Scopus citations

Fingerprint Dive into the research topics of 'A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group'. Together they form a unique fingerprint.

Medicine & Life Sciences